(Q41888478)

13 October 2017

title

Chemotherapeutic prevention of complications caused by vaccinia virus-vectored immunogen (English)

1 reference

13 October 2017

0 references

1 reference

vaccinia virus

1 reference

Tignor GH

1

1 reference

13 October 2017

Kende M

series ordinal

2

1 reference

13 October 2017

Hanham CA

series ordinal

3

1 reference

13 October 2017

language of work or name

English

0 references

publication date

1 June 1992

1 reference

Annals of the New York Academy of Sciences

13 October 2017

published in

1 reference

13 October 2017

volume

653

1 reference

13 October 2017

page(s)

334-343

1 reference

Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene

13 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB19660.X

Present and future applications of vaccinia virus as a vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB19660.X

Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against Rift Valley fever virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB19660.X

Interferon in acute viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB19660.X

10.1111/J.1749-6632.1992.TB19660.X

21 January 2018

Identifiers

DOI

1 reference

13 October 2017

1 reference